BAXALTA
LIVE

Serial Number

79171327

Owner

Baxalta Incorporated

Attorney

A. Tally Eitan

Filing Date

May 12, 2015

Add to watchlist:

No watchlists yet
View on USPTO

BAXALTA Trademark

Serial Number: 79171327 • Registration: 5084124

BAXALTA is a trademark filed by Baxalta Incorporated on May 12, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently registered and active.

Owner Contact Info

Baxalta Incorporated (2 trademarks)

1200 Lakeside Drive
Bannockburn, IL 60015

Entity Type: 03

Trademark Details

Filing Date

May 12, 2015

Registration Date

November 22, 2016

Published for Opposition

February 16, 2016

Goods & Services

[ Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing printed publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care ]

Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents

Medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 13, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Mar 6, 2025 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2025 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 20, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 26, 2023 INPS
INVALIDATION PROCESSED
Oct 26, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 24, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 24, 2023 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 24, 2023 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 24, 2023 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Oct 22, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 21, 2022 NREP
TEAS SECTION 71 RECEIVED
Aug 22, 2022 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 22, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 7, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 22, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2016 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2016 REAP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 1, 2016 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 16, 2016 ETOF
POST PUBLICATION AMENDMENT - ENTERED
Feb 16, 2016 CHPB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 16, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 16, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Feb 13, 2016 GPNX
ASSIGNED TO PETITION STAFF
Feb 5, 2016 APET
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 27, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 27, 2016 NONP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 18, 2016 EPPA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 12, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2015 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 18, 2015 CHAN
ASSIGNED TO LIE
Dec 18, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2015 REAP
REFUSAL PROCESSED BY IB
Sep 25, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 8, 2015 RFCS
REFUSAL PROCESSED BY MPU
Sep 8, 2015 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 8, 2015 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2015 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2015 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 27, 2015 REPR